Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphoma
Evgeny Klyuchnikov(Universität Hamburg), Mehdi Hamadani(Medical College of Wisconsin), Ernesto Ayala(Mayo Clinic in Florida), Sonali M. Smith(University of Chicago), Jonathon B. Cohen(Emory University), Saad Z. Usmani(Memorial Sloan Kettering Cancer Center), Mohamed A. Kharfan‐Dabaja(Jacksonville College), Rodrigo Martino(Universitat Autònoma de Barcelona), Y-B Chen(Harvard University Press), Parameswaran Hari(Medical College of Wisconsin), Harry C. Schouten, Hillard M. Lazarus(University Hospitals of Cleveland), César O. Freytes(CHRISTUS Transplant Institute), Grace Ku(University of California San Diego), Alberto Mussetti(Duran i Reynals Hospital), A I Chen(Oregon Health & Science University), Jeanette Carreras(Medical College of Wisconsin), Baldeep Wirk(Boston University), Ulrike Bacher(Hattiesburg Clinic), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Robert Peter Gale(Imperial College London), Bipin N. Savani(Vanderbilt University Medical Center), Peter H. Wiernik(Albert Einstein College of Medicine), Kwang Woo Ahn(Medical College of Wisconsin), Rammurti T. Kamble(Baylor College of Medicine), Nicolaus Kröger(Universität Hamburg)
Cited by 42
Related Papers
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k
Teclistamab in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2022|1.2k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k